HUGE Mistake: White House MFN Drug Policy Will Devastate Innovation into New Treatments and Cures
November 20, 2020 As a leading advocate for consumers and patients across the country, CASE strongly condemns today’s new...
November 20, 2020 As a leading advocate for consumers and patients across the country, CASE strongly condemns today’s new...
Gerard Scimeca – CASE Chairman October 30, 2020 Two entirely different visions for America are on the ballot this November,...
September 28, 2020 In a move that can only be considered a total disaster for the safety and security...
Gerard Scimeca – CASE September 14, 2020 In the ongoing debate on the best way Washington can help lower...
August 7. 2020 As Americans continue to struggle through the most devastating health crisis in a century, affordability and...
Matthew Kandrach – President, CASE July 4, 2020 Despite lawmakers’ public calls for national unity during this unprecedented public health...
April 16, 2020 On January 21, 2020, the Centers for Disease Control and Prevention (CDC) confirmed the first case...
Gerard Scimeca – Chairman, CASE April 10, 2020 Washington acted swiftly in passing the $2.2 trillion economic relief package to help...
March 20, 2020 Just as America has met every challenge we have faced throughout our history, there is little doubt...
January 29, 2020 Arlington, VA – Today, CASE Vice President Gerard Scimeca issued the following statement upon the signing of...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers